BioSpace News Archive

Biotech Bay

The Rett Syndrome Research Trust Funds Herophilus’ Rett Syndrome Lead Candidate Studies

Herophilus announced that in vivo studies underway of its lead candidate HRP-12975 are funded in part by the Rett Syndrome Research Trust.

January 26, 2023
·
3 min read
European Medicines Agency accepts Marketing Authorization Application for lecanemab as treatment for early Alzheimer’s disease: BioArctic

BioArctic AB’s (publ) (Nasdaq Stockholm: BIOA B) partner Eisai announced today that the European Medicines Agency (EMA) has accepted a marketing authorization application (MAA) for lecanemab (Brand Name in the U.S.: LEQEMBI™).

January 26, 2023
·
6 min read
Rakovina Therapeutics Announces Presentation at the 6th Annual DDR-inhibitors Summit

Rakovina Therapeutics Inc., is pleased to announce a scientific presentation at the 6th Annual DDR Inhibitors Summit in Boston, MA.

January 26, 2023
·
4 min read
BioCapital

ExeGi Pharma Announces Clearance of Investigational New Drug (IND) Application for EXE- 46 a Live Biotherapeutic Biologic Drug

ExeGi Pharma LLC, a leader in the development of live biotherapeutic drugs and probiotics, announced today that the FDA has cleared its Investigational New Drug (IND) application for its biologic drug candidate, EXE-346.

January 26, 2023
·
2 min read
Biotech Bay

Glaucoma Research Foundation Hosts 12th Annual Glaucoma 360 New Horizons Forum in San Francisco

Glaucoma Research Foundation (GRF) will host the 12th Annual Glaucoma 360 New Horizons Forum on February 3rd at San Francisco’s iconic Westin St. Francis Hotel.

January 26, 2023
·
2 min read
Business

Sartorius with clear double-digit growth in fiscal 2022

Following extraordinary growth in 2020 and 2021, the life science group Sartorius again outperformed the market in fiscal 2022, achieving its targets for sales revenue and profitability.

January 26, 2023
·
13 min read
Business

Preliminary results 2022 of Sartorius Stedim Biotech

Following extraordinary growth in 2020 and 2021, Sartorius Stedim Biotech, a leading partner of the biopharma industry, again outperformed the market in fiscal 2022.

January 26, 2023
·
11 min read
Business

Novozymes delivers historically strong full-year results

In the 2022 financial year, Novozymes delivers 9% organic sales growth – 11% organic sales growth in the fourth quarter alone – an EBIT-margin before special items[*] of 26.4%, and ROIC including goodwill before special items* of 17.9%.

January 26, 2023
·
4 min read
Business

Report on Operations 2022

Net sales amounted to SEK 131.5 million (85.9), corresponding to an increase of 53 percent in SEK and 34 percent adjusted for currency effects. Organic growth accounted for 27 percent and acquired growth for 7 percent.

January 26, 2023
·
5 min read
Evotec Announces Agreement with Janssen to Develop Immune-Based Therapies

Evotec SE announced that the Company has entered into a strategic collaboration and licence agreement with Janssen Biotech, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson.

January 26, 2023
·
4 min read